WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read Moreby Emily Kimber | Mar 24, 2025 | News | 0
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read Moreby Chiani-Rae Garland | Oct 30, 2024 | News | 0
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
Read Moreby Emily Kimber | Sep 16, 2024 | News | 0
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Read Moreby Jen Brogan | Oct 19, 2023 | News | 0
The considerations will help to develop new or existing guidance on AI
Read Moreby Fleur Jeffries | Oct 26, 2022 | News | 0
The International AIDS Vaccine Initiative is a global nonprofit scientific research organisation
Read Moreby Lucy Parsons | Feb 11, 2021 | News | 0
WHO’s SAGE panel backs wide use of jab in adults, including in people aged over 65
Read Moreby Lucy Parsons | Jan 28, 2021 | News | 0
The New Variant Assessment Platform will be led by Public Health England
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479